Bringing the fundamentals into focus…
Back to Mesoblast Limited
How Mesoblast Limited stacks up
MESO · against 413 other Healthcare companies of similar size
Profitability
25/ 100
Near the bottom of its peers.
Ranked #326 of 414 · scores higher than 21% of peers
Bars: peers in each 10-point band of the profitability score31 peers with a profitability score of 20–29, including MESO · Click a bar to see the companies
Why profitability scores 25?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 83% of peers. Operating margin: -42.6% vs peer median 7.1%
- a lower return on assets: weaker than 73% of peers. Return on assets: -7.4% vs peer median 1.7%
- a lower return on invested capital: weaker than 71% of peers. Return on invested capital: -5.3% vs peer median 4.7%
Metric by metric
Position: dot = MESO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | MESO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 390 reported | -5.3% | 5.8% | 25% | 33% | |
| Operating marginHigher is better · 381 reported | -42.6% | 7.9% | 13% | 33% | |
| Return on assetsHigher is better · 397 reported | -7.4% | 2.0% | 23% | 33% | |
| Return on equityHigher is better · 382 reported | -9.9% | 4.8% | 27% | Context only | |
| Gross marginHigher is better · 428 reported | 80.0% | 47.6% | 89% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around MESO| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 319 | 1.8B AUD (≈$1.2B) | 27 | 41 | |
| 323 | 9.1B CNY (≈$1.3B) | 26 | 20 | |
| 323 | 12.1B CNY (≈$1.7B) | 26 | 15 | |
| 323 | 3.3B USD | 26 | 44 | |
| 326 | 1.9B USD | 25 | 44 | |
| 326 | 2.0B USD | 25 | 53 | |
| 328 | 12.7B CNY (≈$1.8B) | 24 | 20 | |
| 328 | 1.5B USD | 24 | 44 | |
| 328 | 2.0B USD | 24 | 42 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score